William Porter
Senior Regulatory Analyst
William brings more than 10 years of experience in both drug and device regulatory development, from a 30-page technical file to an 11 million-page NDA. He has worked on early to late phase product development projects for several global pharmaceutical companies including Eli Lilly, Baxter, Abbvie, and AstraZeneca. William has been instrumental in completing a wide range of projects from Clinical TMF migrations, 510ks, EU Technical Files, IND and NDA submissions.
William has also served as project lead on several RIM conversion projects and technical lead for Veeva (RIM) EDMS.
His experience includes regulatory filings with FDA, EMA, Health Canada, as well as health authorities in Asia-Pacific and Latin America.
William holds a B.S. in Biology from Northeastern Illinois University.